Nature Communications (May 2021)

Deep learning predicts cardiovascular disease risks from lung cancer screening low dose computed tomography

  • Hanqing Chao,
  • Hongming Shan,
  • Fatemeh Homayounieh,
  • Ramandeep Singh,
  • Ruhani Doda Khera,
  • Hengtao Guo,
  • Timothy Su,
  • Ge Wang,
  • Mannudeep K. Kalra,
  • Pingkun Yan

DOI
https://doi.org/10.1038/s41467-021-23235-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

Low dose computed tomography (LDCT) for lung cancer screening offers an opportunity for simultaneous CVD risk estimation in at-risk patients. Here, the authors develop a deep learning model to perform this task, showing human-level performance.